首页> 外文OA文献 >Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial

【2h】

Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial

机译：接受放射免疫治疗的局部晚期头颈癌患者的辐射和西妥昔单抗诱导的皮肤反应的区别：HICARE方案（头颈癌：ImmunoChemo和放射治疗）–多中心IV期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
G Habl; K Potthoff; MF Haefner; A Abdollahi; JC Hassel; E Boller; M Indorf; J Debus;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial [J] . G Habl, K Potthoff, MF Haefner, BMC Cancer . 2013,第1期

机译：接受放射免疫治疗的局部晚期头颈癌患者的放射和西妥昔单抗诱导的皮肤反应的区别：HICARE方案（头颈癌：ImmunoChemo和放射治疗）–多中心IV期试验
2. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck [J] . Tomohiro Enokida, Takenori Ogawa, Akihiro Homma, Cancer Medicine . 2020,第5期

机译：紫杉醇，卡铂和西妥昔单抗的多中心期II试验，然后进行患者的头部和颈部局部晚期鳞状细胞癌的患者的化学疗法
3. Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally-advanced head and neck cancer: a randomized phase II trial [J] . Vozy A., Cuenca X. Oncologie. . 2016,第6期

机译：西妥昔单抗和放疗与顺铂和放疗治疗局部晚期头颈癌：一项随机II期试验
4. Effect of Xerostomia on Quality of Life in Head and Neck Cancer Patients Undergoing Radiotherapy at RSUP H. Adam Malik Medan [C] . Aida Fadhilla Darwis, Sayuti Hcisibuan, Nana Nuradinda Tarigan International Dental Conference of Sumatera Utara . 2018

机译：挠性阳瘤对在RSUP H. Adam Malik Medan中放射治疗的头部颈部癌症患者的生活质量
5. National and Institutional Outcomes Data in Head and Neck Cancers, and Functional and Patient Reported Outcomes in Patients with Oropharyngeal Cancers. [D] . Kansal, Ankit. 2017

机译：头颈癌的国家和机构结局数据，以及口咽癌患者的功能和患者报告结局。
6. Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial [O] . G Habl, K Potthoff, MF Haefner, 2013

机译：接受放射免疫治疗的局部晚期头颈癌患者的辐射和西妥昔单抗诱导的皮肤反应的区别：HICARE方案（头颈癌：ImmunoChemo和放射治疗）–多中心IV期试验
7. PCN20 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN THE UNITED KINGDOM [O] . Brown B, Tilden D, Griebsch I, 2007

机译：头孢昔单抗（ERBITUX®）与放射治疗与放射治疗相结合单独治疗PCN20在英国局部先进的头部和颈部癌症中的治疗

Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial

著录项

引文网络

相似文献

相关主题

期刊订阅